Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Sales | 274,719 | 244,733 | 227,559 | 204,047 | 185,699 |
| Cost of Goods | 31,613 | 28,268 | 28,798 | 23,369 | 21,745 |
| Gross Profit | 243,106 | 216,465 | 198,761 | 180,678 | 163,954 |
| Operating Expenses | 160,014 | 146,695 | 124,189 | 114,848 | 115,675 |
| Operating Income | 83,705 | 70,038 | 75,370 | 66,199 | 49,024 |
| Interest Expense | 2,079 | 2,287 | 183 | 204 | 203 |
| Other Income | 96 | 58 | -1,109 | -318 | 266 |
| Pre-tax Income | 81,722 | 67,809 | 74,078 | 65,677 | 49,087 |
| Income Tax | 45,464 | 22,396 | 25,908 | 107 | 14,342 |
| Net Income Continuous | 36,258 | 45,413 | 48,170 | 65,570 | 34,745 |
| Net Income | $36,258 | $45,413 | $48,170 | $65,570 | $34,745 |
| EPS Basic Total Ops | 0.19 | 0.24 | 0.26 | 0.36 | 0.19 |
| EPS Basic Continuous Ops | 0.19 | 0.24 | 0.26 | 0.36 | 0.19 |
| EPS Diluted Total Ops | 0.18 | 0.23 | 0.25 | 0.34 | 0.18 |
| EPS Diluted Continuous Ops | 0.18 | 0.23 | 0.25 | 0.34 | 0.18 |
| EBITDA(a) | $89,249 | $75,913 | $79,760 | $70,494 | $53,504 |